At the beginning of 2024, life felt ordinary in the best possible way for five-year-old Jack and his family. Jack was settling into his first year of school, discovering the small joys that make up childhood. He loved swimming, climbing through soft play structures, and racing through each day with the boundless energy only a five-year-old can have. Nothing about that winter hinted at how dramatically their world was about to change.
One afternoon, when Sarah went to pick Jack up from school, she noticed something small but unsettling: a slight limp. It was easy to dismiss. Children fall, bump into things, and bounce back all the time. Sarah assumed Jack had hurt himself while playing. But the limp didn’t disappear. It lingered for a week. Jack didn’t complain much, but a mother’s instinct is rarely quiet, and Sarah decided to take him to the GP.
The initial explanation brought mild reassurance. The doctor suggested Jack might have a virus causing an irritable hip — something common in children and usually harmless. A few days later, though, Jack became unwell one night, and Sarah’s concern deepened. Another GP visit followed. Again, the answer was vague: it could be viral, it could be an infection. Calpol was recommended, and they were sent home.
But Jack’s body was trying to say something louder.
By the second week, the pain arrived. Jack began waking in the night, crying out. Watching her child suffer without understanding why is a uniquely helpless feeling, and Sarah took him to A&E. An X-ray of his hip showed nothing alarming. She was reassured once more and told to alternate paracetamol and ibuprofen.
That night, everything broke apart.
Jack screamed in pain. At 5 a.m., Sarah called for medical advice and was told to return to A&E and insist on blood tests. When the results came back, they revealed a dangerously high C-reactive protein level — a sign that something serious was happening inside Jack’s body.
From there, events moved fast.
Jack was admitted to hospital. Doctors initially suspected a septic hip, even though imaging showed nothing wrong. He looked well on the outside, which made everything even more confusing. Then came the abdominal ultrasound. What it revealed changed their lives forever: a mass above Jack’s right kidney.
In the days that followed, Jack underwent countless tests and scans. The waiting was unbearable — every hour filled with fear, every conversation edged with dread. On February 15, 2024, Sarah received the words no parent is ever prepared to hear.
Jack had stage 4 high-risk neuroblastoma.
In that single moment, the world Sarah knew disappeared. The future she had imagined for her son fractured into uncertainty, hospital corridors, and treatment plans that stretched far beyond anything she had ever known.
What followed was a year defined by survival.
Jack endured eight rounds of induction chemotherapy. His small body went through a stem cell harvest, followed by major tumour resection surgery. Then came high-dose chemotherapy and a stem cell transplant — treatments so intense they push even adult bodies to their limits. Jack faced them at five years old. After that, he underwent twelve sessions of radiotherapy and six long months of immunotherapy.
Each stage brought new challenges. Nausea, exhaustion, pain, isolation. Days when Jack barely had the strength to sit up. Nights filled with worry and quiet tears. And yet, again and again, Jack surprised everyone.
“The way he bounced back from his lowest moments was incredible,” Sarah says. “We couldn’t be prouder of him.”
Despite his strength, the diagnosis carried a shadow that never left. High-risk neuroblastoma comes with a significant chance of relapse. Even now, that fear lingers. When Jack mentions a sore leg or a tummy ache, Sarah feels her heart race, her mind instantly jumping back to the worst moments.
“You never fully relax,” she admits. “That fear stays with you.”
In April 2025, Jack finished his frontline treatment. He rang the end-of-treatment bell — a moment filled with relief, gratitude, and cautious hope. He is now in remission. For the next two years, he will remain on maintenance treatment designed to reduce the risk of relapse. The journey isn’t over, but it has entered a new chapter.
Jack recently turned seven. He is back at school full-time. He swims again. He plays. He laughs. To the outside world, he looks like any other child his age. But behind that smile is a strength far beyond his years and a family forever changed by what they’ve endured.
Looking back, Sarah reflects on how quickly everything happened — how a small limp turned into a life-altering diagnosis. She also reflects on Jack himself: his courage, his resilience, and his quiet determination to keep going even when his world became unbearably hard.
Today, they are living in the precious space between fear and hope. Grateful for remission. Aware of what could come. Holding tightly to the present.
Jack’s story is not just about cancer. It is about listening to instincts, about how fragile normal life can be, and about the extraordinary bravery of a little boy who faced the unimaginable and came through it still smiling.
For now, Jack is seven years old. He is in school. He is living. And that, after everything, is everything.